CARTI First Site in Nation to Enroll for Imaging Clinical Trial
CARTI First Site in Nation to Enroll for Imaging Clinical Trial LITTLE ROCK, ARK. (Feb. 11, 2019) – CARTI Cancer Center and ImaginAb Inc., an emerging immuno-oncology imaging company, announced the enrollment of the first three patients in the Phase II clinical trial of ImaginAb’s CD8+ T cell imaging agent. CARTI is the first site in the nation … Continued